Life-Space Mobility of Subjects With COPD on Long-Term Oxygen Therapy Delivered by Non-Portable Devices

REFERENCES

1. 1.↵
   1. McDonald CF,
   2. Crockett AJ,
   3. Young IH

   . Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. Med J Aust 2005;182(12):621-626.

   OpenUrlPubMedWeb of Science
2. 2.↵
   1. Hardinge M,
   2. Annandale J,
   3. Bourne S,
   4. Cooper B,
   5. Evans A,
   6. Freeman D,
   7. et al

   ; British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for home oxygen use in adults. Thorax 2015;70 Suppl 1(Suppl 1):i1-43.

   OpenUrlPubMed
3. 3.↵
   1. Sandland CJ,
   2. Singh SJ,
   3. Curcio A,
   4. Jones PM,
   5. Morgan MD

   . A profile of daily activity in chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005;25(3):181-183.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Mazzarin C,
   2. Kovelis D,
   3. Biazim S,
   4. Pitta F,
   5. Valderramas S

   . Physical inactivity, functional status, and exercise capacity in COPD patients receiving home-based oxygen therapy. COPD 2018;15(3):271-276.

   OpenUrlPubMed
5. 5.↵
   1. AlMutairi HJ,
   2. Mussa CC,
   3. Lambert CT,
   4. Vines DL,
   5. Strickland SL

   . Perspectives from COPD subjects on portable long-term oxygen therapy devices. Respir Care 2018;63(11):1321-1330.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Peel C,
   2. Sawyer Baker P,
   3. Roth DL,
   4. Brown CJ,
   5. Brodner EV,
   6. Allman RM

   . Assessing mobility in older adults: the UAB study of aging life-space assessment. Phys Ther 2005;85(10):1008-1119.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Rossler R,
   2. Bridenbaugh SA,
   3. Engelter ST,
   4. Weibel R,
   5. Infanger D,
   6. Giannouli E,
   7. et al

   . Recovery of mobility function and life-space mobility after ischemic stroke: the MOBITEC-Stroke study protocol. BMC Neurol 2020;20(1):348.

   OpenUrl
8. 8.↵
   1. Chung J,
   2. Lee J,
   3. Elswick RK Jr..

   Life-space mobility in dementia patients and family caregivers: a dyadic approach. Int J Older People Nurs 2020;15(4):e12341.

   OpenUrl
9. 9.↵
   1. Ahmed T,
   2. Curcio CL,
   3. Auais M,
   4. Vafaei A,
   5. Pirkle CM,
   6. Guerra RO,
   7. et al

   . Falls and life-space mobility: longitudinal analysis from The International Mobility in Aging Study. Aging Clin Exp Res 2021;33(2):303-310.

   OpenUrl
10. 10.↵
    1. Baker PS,
    2. Bodner EV,
    3. Allman RM

    . Measuring life-space mobility in community-dwelling older adults. J Am Geriatr Soc 2003;51(11):1610-1614.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Uchida K,
    2. Murata S,
    3. Kawaharada R,
    4. Tsuboi Y,
    5. Isa T,
    6. Okumura M,
    7. et al

    . Association between kinesiophobia and life space among community-dwelling older people with chronic musculoskeletal pain. Pain Med 2020;21(12):3360-3365.

    OpenUrl
12. 12.↵
    1. Arya S,
    2. Khakharia A,
    3. Rothenberg KA,
    4. Johnson TM 2nd.,
    5. Sawyer P,
    6. Kennedy RE,
    7. et al

    . Association of peripheral artery disease with life-space mobility restriction and mortality in community-dwelling older adults. J Vasc Surg 2020;71(6):2098-2106.e1. e2091.

    OpenUrl
13. 13.↵
    1. Ishihara K,
    2. Izawa KP,
    3. Kitamura M,
    4. Ogawa M,
    5. Shimogai T,
    6. Kanejima Y,
    7. et al

    . Gait speed, life-space mobility, and mild cognitive impairment in patients with coronary artery disease. Heart Vessels 2021;36(2):147-154.

    OpenUrl
14. 14.↵
    1. Iyer AS,
    2. Wells JM,
    3. Bhatt SP,
    4. Kirkpatrick DP,
    5. Sawyer P,
    6. Brown CJ,
    7. et al

    . Life-space mobility and clinical outcomes in COPD. COPD 2018;Volume 13:2731-2738.

    OpenUrl
15. 15.↵
    1. Garcia IFF,
    2. Tiuganji CT,
    3. Simoes M,
    4. Lunardi AC

    . Activities of daily living and life-space mobility in older adults with chronic obstructive pulmonary disease. COPD 2020;Volume 15:69-77.

    OpenUrl
16. 16.↵
    1. von Elm E,
    2. Altman DG,
    3. Egger M,
    4. Pocock SJ,
    5. Gotzsche PC,
    6. Vandenbroucke JP

    ; Iniciativa STROBE. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Rev Esp Salud Publica 2008;82(3):251-259.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Vestbo J,
    2. Hurd SS,
    3. Rodriguez-Roisin R

    . The 2011 revision of the global strategy for the diagnosis, management, and prevention of COPD (GOLD)–why and what? Clin Respir J 2012;6(4):208-214.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Simoes M,
    2. Garcia IF,
    3. Costa LDC,
    4. Lunardi AC

    . Life-space assessment questionnaire: novel measurement properties for Brazilian community-dwelling older adults. Geriatr Gerontol Int 2018;18(5):783-789.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Mahler DA,
    2. Rosiello RA,
    3. Harver A,
    4. Lentine T,
    5. McGovern JF,
    6. Daubenspeck JA

    . Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis 1987;135(6):1229-1233.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Charlson M,
    2. Szatrowski TP,
    3. Peterson J,
    4. Gold J

    . Validation of a combined comorbidity index. J Clin Epidemiol 1994;47(11):1245-1251.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Katz S,
    2. Akpom CA

    . A measure of primary sociobiological functions. Int J Health Serv 1976;6(3):493-508.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Balestroni G,
    2. Bertolotti G

    . [EuroQol-5D (EQ-5D): an instrument for measuring quality of life]. Monaldi Arch Chest Dis 2012;78(3):155-159.

    OpenUrlCrossRefPubMed
23. 23.
    1. Ringbaek T,
    2. Brondum E,
    3. Martinez G,
    4. Lange P

    . EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients. Respir Med 2008;102(11):1563-1567.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Santos M,
    2. Cintra MA,
    3. Monteiro AL,
    4. Santos B,
    5. Gusmao-Filho F,
    6. Andrade MV,
    7. et al

    . Brazilian valuation of EQ-5D-3L health states: results from a saturation study. Med Decis Making 2016;36(2):253-263.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Bui KL,
    2. Nyberg A,
    3. Maltais F,
    4. Saey D

    . Functional tests in chronic obstructive pulmonary disease, part 2: measurement properties. Ann Am Thorac Soc 2017;14(5):785-794.

    OpenUrlPubMed
26. 26.↵
    1. Albuquerque VS,
    2. Corso SD,
    3. Amaral DP,
    4. Oliveira TMD,
    5. Souza GF,
    6. Souza RNS,
    7. et al

    . Normative values and reference equation for the six-minute step test to evaluate functional exercise capacity: a multicenter study. J Bras Pneumol 2022;48(4):e20210511.
27. 27.↵
    1. Mussa CC,
    2. Tonyan L,
    3. Chen YF,
    4. Vines D

    . Perceived satisfaction with long-term oxygen delivery devices affects perceived mobility and quality of life of oxygen-dependent individuals with COPD. Respir Care 2018;63(1):11-19.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Laviolette L,
    2. Laveneziana P,
    3. Faculty E

    ; ERS Research Seminar Faculty. Dyspnea: a multidimensional and multidisciplinary approach. Eur Respir J 2014;43(6):1750-1762.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Parshall MB,
    2. Schwartzstein RM,
    3. Adams L,
    4. Banzett RB,
    5. Manning HL,
    6. Bourbeau J,
    7. et al

    ; American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185(4):435-452.

    OpenUrlCrossRefPubMedWeb of Science